Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Nov-Dec;92(6):899-900.
doi: 10.1590/abd1806-4841.20177346.

Reactivation of Chagas-Mazza disease during treatment with infliximab

Affiliations
Case Reports

Reactivation of Chagas-Mazza disease during treatment with infliximab

Aldana Soledad Vacas et al. An Bras Dermatol. 2017 Nov-Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interests: Galimberti RL is a senior researcher at Novartis, Eli Lilly and AbbVie

Figures

Figure 1
Figure 1
Erythema and thick scaling of 90% of the body, including face and soles

References

    1. who.int [Internet] Organización Mundial de la salud. La enfermedad de Chagas (Tripanosomiasis americana). Nota descriptiva Nº 340. 2012. [08 Abr 2017]. Disponible em: http://www.who.int/mediacentre/factsheets/fs340/es/index.html.
    1. Riganti J, Maqueda MG, Piñero MC, Volonteri VI, Galimberti RL. Reactivation of Chagas' disease: cutaneous manifestations in two immunosuppressed patients. Int J Dermatol. 2012;51:829–834. - PubMed
    1. Jordan R, Valledor A. Guías de recomendaciones de prevención de infecciones en pacientes que reciben modificadores de la respuesta biológica. Rev Arg Reumatol. 2014;25:8–26.
    1. Pérez AR, Fontanella GH, Nocito AL, Revelli S, Bottasso OA. Short treatment with the tumor necrosis factor-a blocker infliximab diminishes chronic chagasic myocarditis in rats without evidence of Trypanosoma cruzi reactivation. Clin Exp Immunol. 2009;157:291–299. - PMC - PubMed

LinkOut - more resources